Karyopharm Therapeutics (KPTI) Current Assets (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Current Assets of $106.38 million for Q2 2026, up 8.7% from $97.87 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Current Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Current Assets came in at $103.15 million, down 34.1% from FY2024.
- Annual Current Assets has declined for three consecutive years, with a five-year compound annual growth rate of -17.9% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Current Assets was $156.46 million in FY2024 (-33.1%), $233.92 million in FY2023 (-33.2%), $350.16 million in FY2022 (+27.1%) and $275.61 million in FY2021 (-0.3%).
- The Q2 2026 figure stands as the highest quarterly Current Assets since Q1 2025.
- On a year-over-year basis, Current Assets increased in 1 of the last seven quarters, with an average decline of 33.2%.
- The strongest year-over-year quarter for Current Assets in the past five years was Q4 2022, with growth of 27.1%; the weakest was Q2 2025, with a decline of 53.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Karyopharm Therapeutics | 15.30 Mn | -211.13 Mn | 32.35 Mn | 106.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.38 Mn |
| Dec 31, 2025 | 103.15 Mn |
| Sep 30, 2025 | 89.75 Mn |
| Jun 30, 2025 | 97.87 Mn |
| Mar 31, 2025 | 120.24 Mn |
| Dec 31, 2024 | 156.46 Mn |
| Sep 30, 2024 | 184.76 Mn |
| Jun 30, 2024 | 208.54 Mn |
| Mar 31, 2024 | 198.37 Mn |
| Dec 31, 2023 | 233.92 Mn |
| Sep 30, 2023 | 263.22 Mn |
| Jun 30, 2023 | 291.38 Mn |
| Mar 31, 2023 | 318.54 Mn |
| Dec 31, 2022 | 350.16 Mn |
| Sep 30, 2022 | 222.68 Mn |
| Jun 30, 2022 | 242.45 Mn |
| Mar 31, 2022 | 276.53 Mn |
| Dec 31, 2021 | 275.61 Mn |
| Sep 30, 2021 | 241.58 Mn |
| Jun 30, 2021 | 273.50 Mn |
API Access
Karyopharm Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();